Tokman Alexander Y
SEC CIK 1334483 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NDRA | ENDRA Life Sciences Inc. | Dir | 101.9K | $26.9K | — | 5 | 2022-05-16 | 2026-03-02 |
Most active insiders at NDRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Jacroux Richard | CFO | — | — |
| 2 | Basenese Lou | Dir | — | — |
| 3 | Harsh Michael | Dir | — | — |
| 4 | Tokman Alexander Y | CEO, Dir | — | — |
| 5 | DIGIANDOMENICO ANTHONY | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | NDRA | ENDRA Life Sciences Inc. | Tokman Alexander Y | CEO, Dir | A - Grant | $0.00 | +26.9K | 101.9K | +36% | $0 | |
| 2026-01-23 | 2026-01-21 | NDRA | ENDRA Life Sciences Inc. | Tokman Alexander Y | CEO, Dir | A - Grant | $0.00 | +75.0K | 75.0K | +1,500,000% | $0 | |
| 2022-11-28 | 2022-11-23 | NDRA | ENDRA Life Sciences Inc. | Tokman Alexander Y | Dir | P - Purchase | $0.17 | +10.0K | 162.9K | +7% | +$1,700 | |
| 2022-08-24 | 2022-08-22 | NDRA | ENDRA Life Sciences Inc. | Tokman Alexander Y | Dir | P - Purchase | $0.26 | +20.0K | 152.9K | +15% | +$5,200 | |
| 2022-05-17 | 2022-05-16 | NDRA | ENDRA Life Sciences Inc. | Tokman Alexander Y | Dir | P - Purchase | $0.2 | +100.0K | 132.9K | +304% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations